HR 486
108th Congress
House
RU-486 Patient Health and Safety Protection Act
Official title: To require the Food and Drug Administration to establish restrictions regarding the qualifications of physicians to prescribe the abortion drug commonly known as RU-486.
Health
AbortionAdministrative procedureContinuing educationContraceptives
More subjectsShow fewer subjects
CurriculaDepartment of Health and Human ServicesDrug approvalsDrugsEducationGovernment Operations and PoliticsHigher educationImaging systems in medicineLawMedical educationMedical personnelMedical testsPhysiciansPregnancyTransportation and Public WorksTravelWomen
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 14, 2003
Referred to the Subcommittee on Health.
Jan 29, 2003
Referred to the House Committee on Energy and Commerce.
Jan 29, 2003
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Plain-English summary
RU-486 Patient Health and Safety Protection Act - Restricts the prescribing of the drug mifepristone (commonly referred to as RU-486, to be marketed as Mifeprex) to physicians who meet specified requirements.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 486: RU-486 Patient Health and Safety Protection Act. 108th Congress. Open America. https://openamerica.io/bill/108-HR-486/
"H.R. 486: RU-486 Patient Health and Safety Protection Act." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-486/.
H.R. 486, 108th Cong. (2026), https://openamerica.io/bill/108-HR-486/.
[H.R. 486: RU-486 Patient Health and Safety Protection Act](https://openamerica.io/bill/108-HR-486/)